Capital Fund Management (CFM)’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.7M | Sell |
76,600
-16,000
| -17% | -$2.24M | 0.05% | 530 |
|
|
2025
Q4 | $11.4M | Sell |
92,600
-120,800
| -57% | -$14.7M | 0.03% | 754 |
|
|
2025
Q3 | $23.7M | Sell |
213,400
-27,300
| -11% | -$3.1M | 0.06% | 442 |
|
|
2025
Q2 | $26.7M | Sell |
240,700
-276,700
| -53% | -$29.4M | 0.07% | 369 |
|
|
2025
Q1 | $58M | Buy |
517,400
+74,800
| +17% | +$7.72M | 0.17% | 169 |
|
|
2024
Q4 | $40.9M | Sell |
442,600
-393,600
| -47% | -$35.4M | 0.1% | 278 |
|
|
2024
Q3 | $70.1M | Sell |
836,200
-391,800
| -32% | -$29.9M | 0.19% | 137 |
|
|
2024
Q2 | $84.3M | Buy |
1,228,000
+1,102,300
| +877% | +$73.6M | 0.25% | 100 |
|
|
2024
Q1 | $9.21M | Sell |
125,700
-776,900
| -86% | -$59.7M | 0.03% | 772 |
|
|
2023
Q4 | $73.1M | Sell |
902,600
-495,900
| -35% | -$38.6M | 0.2% | 116 |
|
|
2023
Q3 | $105M | Sell |
1,398,500
-169,200
| -11% | -$13M | 0.36% | 51 |
|
|
2023
Q2 | $121M | Buy |
1,567,700
+701,900
| +81% | +$56M | 0.49% | 20 |
|
|
2023
Q1 | $71.8M | Buy |
865,800
+693,300
| +402% | +$57.4M | 0.34% | 58 |
|
|
2022
Q4 | $14.8M | Buy |
172,500
+99,100
| +135% | +$7.85M | 0.1% | 279 |
|
|
2022
Q3 | $4.53M | Sell |
73,400
-196,300
| -73% | -$12.4M | 0.04% | 574 |
|
|
2022
Q2 | $16.7M | Sell |
269,700
-32,500
| -11% | -$2.01M | 0.15% | 173 |
|
|
2022
Q1 | $18M | Buy |
302,200
+221,700
| +275% | +$14.2M | 0.15% | 194 |
|
|
2021
Q4 | $5.85M | Sell |
80,500
-336,100
| -81% | -$23.1M | 0.04% | 574 |
|
|
2021
Q3 | $29.1M | Sell |
416,600
-412,400
| -50% | -$29M | 0.22% | 114 |
|
|
2021
Q2 | $57.1M | Sell |
829,000
-162,800
| -16% | -$10.9M | 0.45% | 36 |
|
|
2021
Q1 | $64.1M | Buy |
991,800
+224,900
| +29% | +$14.5M | 0.71% | 14 |
|
|
2020
Q4 | $44.7M | Buy |
766,900
+697,400
| +1,003% | +$42.1M | 0.42% | 45 |
|
|
2020
Q3 | $4.39M | Buy |
+69,500
| New | +$4.82M | 0.05% | 384 |
|
|
2019
Q1 | – | Sell |
-66,900
| Closed | -$4.18M | – | 1827 |
|
|
2018
Q4 | $4.18M | Sell |
66,900
-11,100
| -14% | -$776K | 0.04% | 574 |
|
|
2018
Q3 | $6.02M | Buy |
78,000
+23,600
| +43% | +$1.78M | 0.03% | 684 |
|
|
2018
Q2 | $3.85M | Sell |
54,400
-9,700
| -15% | -$685K | 0.02% | 838 |
|
|
2018
Q1 | $4.83M | Buy |
64,100
+17,100
| +36% | +$1.36M | 0.03% | 699 |
|
|
2017
Q4 | $3.37M | Sell |
47,000
-208,500
| -82% | -$15.8M | 0.02% | 808 |
|
|
2017
Q3 | $20.7M | Buy |
255,500
+233,800
| +1,077% | +$17.9M | 0.15% | 182 |
|
|
2017
Q2 | $1.54M | Sell |
21,700
-72,300
| -77% | -$4.81M | 0.01% | 787 |
|
|
2017
Q1 | $6.38M | Buy |
+94,000
| New | +$6.61M | 0.05% | 391 |
|
|
2016
Q3 | – | Sell |
-6,400
| Closed | -$534K | – | 1652 |
|
|
2016
Q2 | $534K | Sell |
6,400
-7,700
| -55% | -$683K | 0.01% | 1153 |
|
|
2016
Q1 | $1.29M | Sell |
14,100
-4,200
| -23% | -$379K | 0.01% | 814 |
|
|
2015
Q4 | $1.85M | Sell |
18,300
-78,300
| -81% | -$8.15M | 0.02% | 704 |
|
|
2015
Q3 | $9.48M | Buy |
96,600
+91,400
| +1,758% | +$10.2M | 0.11% | 250 |
|
|
2015
Q2 | $609K | Sell |
5,200
-41,100
| -89% | -$4.49M | 0.01% | 1009 |
|
|
2015
Q1 | $4.54M | Sell |
46,300
-551,600
| -92% | -$56M | 0.06% | 365 |
|
|
2014
Q4 | $56.4M | Buy |
597,900
+138,000
| +30% | +$14.3M | 0.67% | 11 |
|
|
2014
Q3 | $49M | Sell |
459,900
-375,100
| -45% | -$36.7M | 0.55% | 18 |
|
|
2014
Q2 | $69.2M | Buy |
835,000
+734,400
| +730% | +$57.2M | 0.73% | 6 |
|
|
2014
Q1 | $7.13M | Sell |
100,600
-25,100
| -20% | -$1.97M | 0.09% | 261 |
|
|
2013
Q4 | $9.45M | Sell |
125,700
-105,200
| -46% | -$7.33M | 0.12% | 211 |
|
|
2013
Q3 | $14.5M | Buy |
230,900
+34,900
| +18% | +$2.09M | 0.2% | 114 |
|
|
2013
Q2 | $10M | Buy |
+196,000
| New | +$10.2M | 0.15% | 155 |
|
Other funds holding GILD
VCM
VPM
Capital Fund Management (CFM)'s GILD Position: Q1 2026 in Review
Capital Fund Management (CFM) increased its Gilead Sciences (GILD) stake by 97% in Q1 2026, buying an estimated $5.06M and bringing the position to 73,592 shares worth $10.3M. The position accounts for 0.05% of the portfolio, ranked #542.
Capital Fund Management (CFM) first reported a position in GILD in Q2 2013 and has held it in 36 quarters since. The position peaked at $94.3M in Q1 2016. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Capital Fund Management (CFM) held 73,592 shares of Gilead Sciences worth $10.3M as of Q1 2026.
- Capital Fund Management (CFM) bought 36,156 Gilead Sciences shares in Q1 2026, an estimated $5.06M.
- Gilead Sciences made up 0.05% of Capital Fund Management (CFM)'s portfolio in Q1 2026, its #542 holding.
- Capital Fund Management (CFM) first reported a position in Gilead Sciences in Q2 2013 and has held it in 36 quarters since.
- Capital Fund Management (CFM)'s Gilead Sciences position peaked at $94.3M in Q1 2016.
- 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Capital Fund Management (CFM)'s 13F filing for Q1 2026, filed 14 May 2026.